56160
4-Hydroxy-L-phenylglycine
≥99.0% (NT)
Manufacturer: Sigma Aldrich
CAS Number: 32462-30-9
Synonym(S): (2S)-2-Amino-2-(4-hydroxyphenyl)acetic acid, Oxfenicine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 G | 56160-10-G | In Stock | ₹ 7,804.83 |
| 50 G | 56160-50-G | In Stock | ₹ 31,197.65 |
56160 - 10 G
In Stock
Quantity
1
Base Price: ₹ 7,804.83
GST (18%): ₹ 1,404.869
Total Price: ₹ 9,209.699
Quality Level
100
Assay
≥99.0% (NT)
form
solid
optical activity
[α]20/D +158±3°, c = 1% in 1 M HCl
reaction suitability
reaction type: solution phase peptide synthesis
application(s)
peptide synthesis
SMILES string
N[C@H](C(O)=O)c1ccc(O)cc1
InChI
1S/C8H9NO3/c9-7(8(11)12)5-1-3-6(10)4-2-5/h1-4,7,10H,9H2,(H,11,12)/t7-/m0/s1
InChI key
LJCWONGJFPCTTL-ZETCQYMHSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | eMolecules Pharmablock / (2S)-2-amino-2-(4-hydroxyphenyl)acetic acid / 25mg / 731743533 / PBA0579 / 0.000 / 32462-30-9 / MFCD00065932 / 167.164 / C8H9NO3 | eMolecules | ₹ 2,854.28 | |
 | Oxfenicine | ChemScene | ₹ 3,336.84 - ₹ 53,047.20 |
Related Products
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P271 - P301 + P312 - P302 + P352 - P305 + P351 + P338
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Compare Similar Items
Show Difference
Quality Level: 100
Assay: ≥99.0% (NT)
form: solid
optical activity: [α]20/D +158±3°, c = 1% in 1 M HCl
reaction suitability: reaction type: solution phase peptide synthesis
application(s): peptide synthesis
SMILES string: N[C@H](C(O)=O)c1ccc(O)cc1
InChI: 1S/C8H9NO3/c9-7(8(11)12)5-1-3-6(10)4-2-5/h1-4,7,10H,9H2,(H,11,12)/t7-/m0/s1
InChI key: LJCWONGJFPCTTL-ZETCQYMHSA-N
Quality Level:
100
Assay:
≥99.0% (NT)
form:
solid
optical activity:
[α]20/D +158±3°, c = 1% in 1 M HCl
reaction suitability:
reaction type: solution phase peptide synthesis
application(s):
peptide synthesis
SMILES string:
N[C@H](C(O)=O)c1ccc(O)cc1
InChI:
1S/C8H9NO3/c9-7(8(11)12)5-1-3-6(10)4-2-5/h1-4,7,10H,9H2,(H,11,12)/t7-/m0/s1
InChI key:
LJCWONGJFPCTTL-ZETCQYMHSA-N
Quality Level: 100
Assay: __
form: __
optical activity: __
reaction suitability: reaction type: Grignard Reaction
application(s): __
SMILES string: I[Mg]c1ccsc1
InChI: 1S/C4H3S.HI.Mg/c1-2-4-5-3-1;;/h1,3-4H;1H;/q;;+1/p-1
InChI key: LDERXYCTDNLPTD-UHFFFAOYSA-M
Quality Level:
100
Assay:
__
form:
__
optical activity:
__
reaction suitability:
reaction type: Grignard Reaction
application(s):
__
SMILES string:
I[Mg]c1ccsc1
InChI:
1S/C4H3S.HI.Mg/c1-2-4-5-3-1;;/h1,3-4H;1H;/q;;+1/p-1
InChI key:
LDERXYCTDNLPTD-UHFFFAOYSA-M
Quality Level: 100
Assay: __
form: __
optical activity: __
reaction suitability: reaction type: Grignard Reaction
application(s): __
SMILES string: Br[Mg]CCC1OCCCO1
InChI: 1S/C6H11O2.BrH.Mg/c1-2-6-7-4-3-5-8-6;;/h6H,1-5H2;1H;/q;;+1/p-1
InChI key: JYNXRXBIEHSSLR-UHFFFAOYSA-M
Quality Level:
100
Assay:
__
form:
__
optical activity:
__
reaction suitability:
reaction type: Grignard Reaction
application(s):
__
SMILES string:
Br[Mg]CCC1OCCCO1
InChI:
1S/C6H11O2.BrH.Mg/c1-2-6-7-4-3-5-8-6;;/h6H,1-5H2;1H;/q;;+1/p-1
InChI key:
JYNXRXBIEHSSLR-UHFFFAOYSA-M
Quality Level: 100
Assay: __
form: __
optical activity: __
reaction suitability: reaction type: Grignard Reaction
application(s): __
SMILES string: Br[Mg]c1cccc2ccccc12
InChI: 1S/C10H7.BrH.Mg/c1-2-6-10-8-4-3-7-9(10)5-1;;/h1-7H;1H;/q;;+1/p-1
InChI key: PZIIGUMPOSVMSD-UHFFFAOYSA-M
Quality Level:
100
Assay:
__
form:
__
optical activity:
__
reaction suitability:
reaction type: Grignard Reaction
application(s):
__
SMILES string:
Br[Mg]c1cccc2ccccc12
InChI:
1S/C10H7.BrH.Mg/c1-2-6-10-8-4-3-7-9(10)5-1;;/h1-7H;1H;/q;;+1/p-1
InChI key:
PZIIGUMPOSVMSD-UHFFFAOYSA-M